Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: DQ Entertainment, Tristel, ReNeuron

Tue, 03rd Apr 2012 12:39

DQ Entertainment, a producer of animation, visual effects, game art and live action entertainment content for the global media and entertainment industry, has won three new contracts for co-production. The first is with French broadcaster TF1 for the new 3D animated TV series of Robin Hood, the second is with Minika ATV for its new kids network in Turkey and the third is with Gaurmont Alphanim for the new 3D animated CGI TV series "Lanfeust". Tristel, a manufacturer of infection control, contamination control and hygiene products, has terminated its supply arrangement with Medichem International for disinfectants and cleaning products. Tristel will now directly market these products to veterinary practices, hospitals under Tristel related brands. Tristel is now free to address the veterinary market directly and to broaden its product offering within areas that it had not been directly involved with, including its core hospital marketplace. ReNeuron Group, a UK-based stem cell company, has announced a firm placing to raise up to £9.4m before expenses with the shares being sold at 4p each. The issue price represents a discount of around 21.2% to the mid-market closing price of 5.075p on the day before the placing was announced. In addition, investors in the placing are being issued warrants to subscribe for ordinary shares, which could raise up to another £8.1m for the company, before expenses, if the warrants are exercised. The company also said that to date no adverse reactions had been seen in the five stroke patients who have been administered with its ReN001 stem cell therapy treatment. The company expects to be able to apply for a phase II study next year. NR
More News
14 Jul 2021 15:15

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

Read more
8 Jul 2021 11:38

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

Read more
1 Jul 2021 17:05

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

Read more
9 Jun 2021 17:47

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

Read more
20 May 2021 20:23

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

Read more
19 Mar 2021 16:43

ReNeuron signs new collaboration agreements

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced the signing of new collaboration agreements with a major pharmaceutical company and leading academic institutions in the UK and mainland Europe on Friday.

Read more
19 Mar 2021 11:34

ReNeuron inks commercial collaboration deals for exosome platform

ReNeuron inks commercial collaboration deals for exosome platform

Read more
19 Mar 2021 11:20

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

Read more
12 Mar 2021 15:39

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

Read more
27 Jan 2021 13:43

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

Read more
15 Jan 2021 15:29

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

Read more
17 Dec 2020 22:00

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

Read more
11 Dec 2020 14:26

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

Read more
24 Nov 2020 14:41

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

Read more
23 Nov 2020 19:09

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.